Aligos Therapeutics Inc Ownership
$5.04
6.00%
Nasdaq, Nov 04, 01:40 pm EST.
Market open.
Aligos Therapeutics Inc Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Deep Track Capital LP
|
444.110k | 7.12% | — | Jun 30 2026 |
| 2 |
Roche Holding AG
|
441.037k | 7.07% | — | Mar 31 2026 |
| 3 |
Alyeska Investment Group, L.P.
|
412.000k | 6.60% | — | Jun 30 2026 |
| 4 |
Sio Capital Management, LLC
|
327.237k | 5.24% | — | Jun 30 2026 |
| 5 |
Marshall Wace LLP
|
246.579k | 3.95% | -20.556k | Jun 30 2026 |
|
1
Deep Track Capital LP
|
7.12%
444.110k
|
|
2
Roche Holding AG
|
7.07%
441.037k
|
|
3
Alyeska Investment Group, L.P.
|
6.60%
412.000k
|
|
4
Sio Capital Management, LLC
|
5.24%
327.237k
|
|
5
Marshall Wace LLP
|
3.95%
246.579k
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 29.98% of Aligos Therapeutics Inc, with Deep Track Capital LP the biggest at 7.12%, followed by Roche Holding AG (7.07%) and Alyeska Investment Group, L.P. (6.60%). |
Aligos Therapeutics Inc Short interest
Powered by
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Aligos Therapeutics Inc has risen over the past 12 months from around 3.9% to 13.3% of the float. More and more market participants are betting on falling prices. That reflects growing skepticism, but also carries upside potential through a possible short squeeze. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
